Debate erupts over off-label COVID vaccine use for children under the age of five 0 21.02.2022 00:16 New York Post After the FDA delayed authorization of the Pfizer-BioNTech COVID-19 vaccine last week for children under the age of five, parents are making a passionate plea for its off-label use. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
